Sorted By:


New Report Shows More than 240 Immuno-Oncology Treatments in Development for Patients with Cancer

PhRMA  |  Press Release

While new approvals in recent years represent significant advances for patients, biopharmaceutical research companies are committed to continuing to seek new cancer treatments and potential cures for America’s patients.

Research & Hope Awards

PhRMA  |  Press Release

To learn about the nearly 300 vaccines in development for both preventative and therapeutic uses, see PhRMA’s new Vaccines in Development report.

Wanted: A Balanced Discussion on Health Care Costs

PhRMA  |  Blog Post

In fact, the share of dispensed generic prescriptions continues to increase, and 4 out of every 5 prescriptions are now filled with a generic.

Formulary Tiers by Exchange Plan

PhRMA  |  Graphic


Former law enforcement officials raise concerns with drug importation proposals

PhRMA  |  Blog Post

I've seen the corpses and stood in front of the grieving families.

Elizabeth Zabell Edelman of Diabetes Daily talks to PhRMA

PhRMA  |  Video

Here she talks about the daily fears, frustrations and triumphs of living with diabetes.

Working to harness the power of the body’s own immune system

PhRMA  |  Blog Post

To see more about the new era of medicine, visit

Principles On Responsible Sharing of Truthful and Non-Misleading Information About Medicines with Health Care Professionals and Payers

PhRMA  |  Codes & Guidelines

In order to support the best use of scientific information for patient care, PhRMA, BIO and our member companies have endorsed Principles on Responsibl...

What They Are Saying: Close Patent Loopholes That Threaten Innovation for Patients

PhRMA  |  Blog Post

” – Joseph Walker and Rob Copeland of The Wall Street Journal, April 7, 2015.

Aspen Spotlight Health 360° VIDEO PREMIERE:
New Virtual Reality Video Takes You Inside The Lab with Researchers to Showcase Amazing Advancements in Medicine

PhRMA  |  Press Release

Ubl, President & CEO of PhRMA, will participate in a panel discussion Friday morning June 23rd examining the value medicines bring patients and how payment and delivery systems can meet 21st century demands.

Improving Adherence Increases Productivity

Chartpack  |  From Our Network

There are fewer days of absence and short-term disability for adherent patients as opposed to nonadherent patients.

UK Cancer Patients Face Increasing Coverage Restrictions Due to Centralized Cost-Effectiveness Standard, New Report Shows

PhRMA  |  Press Release

“The fact that the same body of high quality evidence can elicit such different decisions reveals the subjective nature of these assessments.”

How to get value assessment frameworks right

PhRMA  |  Blog Post

View the full set of principles here.

Medicare Monday: How Part D Helps Save Lives

PhRMA  |  Blog Post

In fact, the total benefit exceeds the total estimated additional spending on cardiovascular drugs from the program of $3.8 billion.”

Prescription Drug Misuse, Abuse & Disposal

PhRMA  |  From PhRMA

For more information and a comprehensive overview of these policies, please see PhRMA’s Reducing Prescription Drug Misuse and Abuse policies document.

Medicare Monday: A guide to MedPAC’s Part B vote this week

PhRMA  |  Blog Post

Keep an eye on MedPAC activity later this week to see what happens with these draft recommendations.

How patients with heart failure save with Medicare Part D

PhRMA  |  Graphic


Senior Manager – Policy and Research

PhRMA  |  PhRMA Career

What we offer In addition to a highly competitive salary, generous 401(k) employer contribution, and platform of benefits (health, dental, vision, life and AD&D, short and long term disability, long term care, and Metro benefit), PhRMA is committed to the development and overall wellbeing of its staff.

Week in Review: The latest from PhRMA

PhRMA  |  Blog Post

Read what stakeholders across the health care system are saying about this innovative set of treatments.

Coverage vs. Access: Ensuring Patients Can Get the Medicines They Need

Access Better Coverage  |  From Our Network

Even more concerning is a report released last week from Avalere Health which found that even after patients meet any deductible they may still be on the hook for thousands of dollars in additional out-of-pocket expenses to access treatments for some of the most debilitating chronic diseases.

What they are saying: Study on cancer R&D costs is not an accurate representation of marketplace

PhRMA  |  Blog Post

This one fails the test… The cost of developing so many drugs in parallel would be well beyond the resources of the small companies in the sample.” – Bernard Munos, senior fellow, FasterCures “There are a number of serious flaws with this study… Most importantly, it includes only a small set of companies that were relatively successful in development during the period they analyzed.

Burden on patients: Insurance benefit design’s impact on patient access to medicines

PhRMA  |  Blog Post

Check out the map and state-specific fact sheets here.

Strength in Numbers to Strengthen the System

PhRMA  |  Blog Post

Watching the Senate floor debate on Senator Patrick Leahy's patent reform bill, we were quite pleased to see the vast, vast majority of senators - 87 of them, in fact - vote to maintain the America Invents Act's first-to-file provision.

Introducing clinical research participation to the everyday person

PhRMA  |  Blog Post

While it may seem like there’s a lot to learn about the clinical research process, reading this post has already put you ahead of the game.

America’s Biopharmaceutical Companies Launch Groundbreaking, Multi-Year Initiative Heralding New Era of Medicine

PhRMA  |  Press Release

#GoBoldly will be used across social media platforms to salute the sheer will and tenacity of patients and scientists fighting against disease every day.

You have reviewed the first 325 results out of 1200. Each page contains 25 results. You're on page 13.

prev 13 14 15 16 17 18 next